Polypharmacy in Psychiatry Practice, Volume I: Multiple Medication Use Strategies by Michael S RitsnerPolypharmacy in Psychiatry Practice, Volume I: Multiple Medication Use Strategies by Michael S Ritsner

Polypharmacy in Psychiatry Practice, Volume I: Multiple Medication Use Strategies

byMichael S Ritsner

Paperback | February 8, 2015

Pricing and Purchase Info

$227.75 online 
$275.95 list price save 17%
Earn 1,139 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in psychiatric practice, reasons, efficacy and safety for polypharmacy, and augmentative strategies have remained unclear. It remains unclear if there is an evidence base to support polypharmacy. Furthermore, excessive and inappropriate use of psychotropic medications has been recognized as a public health problem. This volume set is the first comprehensive, clinically oriented, reference on the multiple medication use to treat psychotic, cognitive, mood and anxiety disorders.
Title:Polypharmacy in Psychiatry Practice, Volume I: Multiple Medication Use StrategiesFormat:PaperbackDimensions:287 pagesPublished:February 8, 2015Publisher:Springer-Verlag/Sci-Tech/TradeLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:9401785120

ISBN - 13:9789401785129

Look for similar items by category:


Table of Contents

About the Editor



Part I. Polypharmacy treatment strategies

1. Multiple medication use in psychiatry: How Rational Can It Be?Ahsan Khanand Sheldon Preskorn

2. Receptor binding targets for antipsychotic efficacy;Maureen M. Grainger, Rebecca Ahlbrand, Paul S. Horn, Neil M. Richtand

3. Drug interactions and polypharmacy;Jessica L. Gören,and Ashley Tewksbury

4. Preclinical and clinical investigation of antipsychotic polypharmacy: What is the evidence?Dimitrios Kontis, Eirini Theochari

5. Should high dose or very long-term antipsychotic monotherapy be considered before antipsychotic polypharmacy?Stephen M. Stahl and Debbi A. Morrissette

6. Multiple Medication Use of Neuropsychiatry in Forensic Psychiatry: Findings from the Central State Forensic Psychiatric Hospital of Saxony-Anhalt;Joachim G. Witzel

Part II. Augmentation strategies

7. Antipsychotic treatment within a naturalistic trial - how are we treating schizophrenia patients in the "real-world"?Rebecca Schennach,Michael Obermeier, Florian Seemüller, Daniela Krause, Richard Musil, Ilja Spellmann, Hans-Jürgen Möller, Michael Riedel

8. A multi-target drug treatment in schizophrenia using adjunctive agents with non-D2mechanisms of action;Michael S Ritsner

9. Antidepressants in schizophrenia - a place for them?Viacheslav Terevnikov and Grigori Joffe

10. Stressful life events and anticonvulsant medication in psychiatric patients;Petr Bob

11. Multiple medication use in somatic symptom disorders: from augmentation to diminution strategies;Adrian P. Mundt

Appendix;Rena Kurs

Annotated bibliography on polypharmacy

List of Psychotropic Medications

Contents to Volume II

Contributors to Volume II